Spontaneous Bacterial Peritonitis Clinical Trial
Official title:
Evaluation of IL-6 and IL-8 Interleukin Rates to Diagnose Spontaneous Bacterial Peritonitis
Spontaneous bacterial peritonitis (SBP), an infection of ascitic fluid in the absence of
localized intra-abdominal infection, is one of the main potentially fatal complications of
cirrhosis. In the case of SBP, early diagnosis and rapid therapeutic care can improve patient
survival (Garcia-Tsao, 2001).
The diagnosis of SBP is based on the detection of a polymorphonuclear neutrophils count equal
to or greater than 250 /mm3 in the ascitic fluid (method of reference). However, obtaining an
ascitic cell count is sometimes difficult because it can not always be performed in emergency
especially outside the opening hours of the laboratory of Bacteriology. This raises the
necessity of developing quick and easy alternative approaches of diagnosis.
Few groups have proposed the use of urinary reagent strip for rapid diagnosis of SBP.
Nevertheless, the investigators clinical teams have shown that the sensitivity of this test
was low in a large national multicenter prospective study involving more than a thousand
patients (Nousbaum et al., 2007). The use of Multistix strips test is thus not recommended
for the routine application of diagnosis of SBP due to its lack of sensitivity.
Although performed on small groups of patients, several studies have reported that IL-8 or
IL-6 might be used as markers of ascitic fluid infections. Based on these data and confirmed
by the investigators preliminary results the investigators propose to study on a broad
recruitment of patients estimated to about 500 inclusions (about 45 infected patients) the
interest of using IL-8 and IL-6 as predictive markers of SBP. The investigators propose to
use an ELISA method, standardized, rapid and automated, applicable in the context of
emergency (7 days a week and 24 hours a day) as previously described in the work conducted to
exclude the urinary tract infection (Oregioni et al., 2005).
During the preliminary experiments conducted for this project, the investigators also found
systematic variation of another marker, leptin. This is a protein hormone involved in the
inflammatory and immune responses (Otero et al., 2005). It appears necessary to include the
study of this marker in the analysis of differential protein response between patients
suffering or not suffering from SBP.
The investigators therefore propose a diagnostic study, non-interventional, prospective,
multicenter trial conducted over 2 years.
- The main objective is to establish the diagnostic performance (sensitivity, specificity,
positive predictive value and negative) of IL-8 and IL-6, assayed in the ascites fluid
by an automated ELISA in the early diagnosis of SBP.
- The secondary objectives are to confirm the interest of the measurement of leptin in the
SBP and to establish the diagnostic performance of IL-8 and IL-6 or leptin according to
different clinical features in patients (score Child-Pugh classification and history of
SBP, ascitic fluid infection with positive bacterial culture).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06026267 -
Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis
|
N/A | |
Withdrawn |
NCT02552862 -
Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)
|
Phase 3 | |
Completed |
NCT02528097 -
A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
|
N/A | |
Completed |
NCT00359853 -
Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
|
Phase 4 | |
Active, not recruiting |
NCT04159870 -
Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis
|
Phase 3 | |
Completed |
NCT04153604 -
Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis
|
||
Completed |
NCT06234046 -
Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin
|
Phase 3 | |
Recruiting |
NCT01598870 -
Diagnosis of Spontaneous Bacterial Peritonitis
|
N/A | |
Recruiting |
NCT00761098 -
Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)
|
Phase 4 | |
Completed |
NCT05401721 -
Serum Copeptin in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
|
||
Completed |
NCT02468089 -
To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis
|
N/A | |
Not yet recruiting |
NCT04746937 -
Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis
|
Phase 3 | |
Recruiting |
NCT02759497 -
Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis
|
N/A | |
Completed |
NCT02608658 -
Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites
|
N/A | |
Completed |
NCT02388035 -
Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis
|
N/A | |
Completed |
NCT03163745 -
Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis
|
||
Completed |
NCT04273373 -
Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.
|
N/A | |
Active, not recruiting |
NCT04395365 -
Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis
|
Phase 3 | |
Terminated |
NCT00570960 -
Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis
|
Phase 4 | |
Recruiting |
NCT05422118 -
Ascitic Fluid Calprotectin as an Accurate Diagnostic Marker for Spontaneous Bacterial Peritonitis
|
N/A |